Lungs News and Research

RSS

New spray protocol improves delivery of nasal antiseptic to reduce COVID-19 infection

A trip to visit family in Kolkata, India, put South Dakota State University assistant professor Saikat Basu in the middle of that country's second wave of COVID-19 infections.

10 May 2021

Researchers improve method to inhibit viruses that cause childhood respiratory infections

By engineering a short chunk of protein, or peptide, that can prevent the attachment of human parainfluenza viruses to cells, researchers have improved a method in rodent models intended to help keep children healthy.

10 May 2021

Researchers identify first biomarker to predict severity of COVID-19

Severe cases of COVID-19 can now be detected at an early stage. Researchers at the University of Zurich have identified the first biomarker that can reliably predict which patients will develop severe symptoms.

10 May 2021

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Neurological problems during and after COVID-19 are persistent and frequent. However, research is still ongoing as to why certain people exhibit specific symptoms. Research led by Yi-Ping Hsueh from the Institute of Molecular Biology in Taiwan suggests SARS-CoV-2 infection in the brain could be sex-dependent.

10 May 2021

Prevalence of SARS-CoV-2 antibodies in Germany

Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.

10 May 2021

Is COVID-19 a new disease?

In a review recently published in The Lancet Respiratory Medicine journal by Osuchowski et al. (May 6th, 2021) the currently known pathophysiology of COVID-19 is laid out to describe the mechanistic features that make COVID-19 distinct from many conditions previously thought to be similar.

9 May 2021

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival. The study is currently available on the bioRxiv* preprint server.

9 May 2021

Learning health system approach can help reduce the risk of hospital-acquired pressure injuries

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes - particularly when it came to strategies aimed at reducing the risk of hospital-related complications.

7 May 2021

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

7 May 2021

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19

A new study has shown that most patients discharged from hospital after experiencing severe COVID-19 infection appear to return to full health, although up to a third do still have evidence of effects upon the lungs one year on.

6 May 2021

Could stem cells improve the outcome of ARDS in severe COVID-19?

A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.

6 May 2021

Monocytes promote viral control during SARS-COV-2 infection

In a paper recently uploaded to the preprint server bioRxiv by Vanderheiden et al. (May 4th, 2021) the contribution of monocytes in promoting protective immunity from SARS-CoV-2 is investigated in a murine model, suggesting that CCR2 plays the role of an inflammation modulator in early infection.

6 May 2021

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 -; the virus that causes COVID 19 -; confers some protection for people who have received solid organ transplants, it's still not enough to enable them to dispense with masks, physical distancing and other safety measures.

6 May 2021

The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications

CN Bio today announced the U.S. Food and Drug Administration (FDA) has extended their research collaboration, for a further three years.

From CN-Bio 5 May 2021

Asthma Awareness: Fighting Asthma in 2021

In light of World Asthma Day, News-Medical interviewed Dr. Samantha Walker from Asthma UK and the British Lung Foundation about fighting asthma in 2021.

5 May 2021

World Asthma Day 2021: How could smart inhalers improve asthma care?

For World Asthma Day 2021, News-Medical interviews Krisnah Poinasamy from Asthma UK about smart inhalers and their benefits for improving asthma care.

5 May 2021

Mechano-immunological response to SARS-CoV-2

In a recent study, researchers demonstrated a human organ-on-a-chip (Organ Chip) microfluidic model of the lung alveolus (Alveolus Chip) - that recapitulates the human alveolar-capillary interface with an air-liquid interface (ALI) and vascular fluid flow to understand the local triggers in the lung in vitro.

5 May 2021

Researchers use 3-D bioprinting to create custom-shaped cartilage for use in surgical procedures

A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.

5 May 2021

Study uncovers protein 'signature' of severe COVID-19

Researchers at Massachusetts General Hospital have identified the protein "signature" of severe COVID-19, which they describe in a new study published in Cell Reports Medicine.

4 May 2021

Study shows potential of human mesenchymal stem cells to treat chronic lung infections

A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection.

4 May 2021

Lungs News and Research

New spray protocol improves delivery of nasal antiseptic to reduce COVID-19 infection

Researchers improve method to inhibit viruses that cause childhood respiratory infections

Researchers identify first biomarker to predict severity of COVID-19

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Prevalence of SARS-CoV-2 antibodies in Germany

Is COVID-19 a new disease?

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Learning health system approach can help reduce the risk of hospital-acquired pressure injuries

Study may lead to personalized treatments for cystic fibrosis

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19

Could stem cells improve the outcome of ARDS in severe COVID-19?

Monocytes promote viral control during SARS-COV-2 infection

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications

Asthma Awareness: Fighting Asthma in 2021

World Asthma Day 2021: How could smart inhalers improve asthma care?

Mechano-immunological response to SARS-CoV-2

Researchers use 3-D bioprinting to create custom-shaped cartilage for use in surgical procedures

Study uncovers protein 'signature' of severe COVID-19

Study shows potential of human mesenchymal stem cells to treat chronic lung infections

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News